Thromboembolic complications following tissue plasminogen activator therapy in patients of acute ischemic stroke - Case report and possibility for detection of cardiac thrombi
Author:
Yamaguchi Junko1, Kinoshita Kosaku2, Hirabayashi Marina1, Hori Satoshi1, Furukawa Makoto1, Sakurai Atsushi1
Affiliation:
1. Division of Emergency and Critical Care Medicine , Department of Acute Medicine, Nihon University School of Medicine , 30-1 Oyaguchi Kamimachi, Itabashi-ku , Tokyo Japan 2. 30-1 Oyaguchi Kamimachi, Itabashi-ku , Tokyo , 173-8610 , Japan
Abstract
Abstract
Many reports focus on the probability of intracranial hemorrhage as a complication after recombinant tissue plasminogen activator (rt-PA) therapy. However, thromboembolic complications are not well discussed. We experienced a case in which severe thromboembolic complications occurred in the right radial and right ulnar artery. Arterial fibrillation was observed in this case. If multiple thrombi exist in the atrium or ventricle, multiple small embolic particles may appear following thrombolytic therapy, and that may be a potential risk of secondary thromboembolic complications due to incomplete dissolution of thrombi. Transesophageal echocardiography is a standard method to detect intracardiac sources of emboli in the case of arterial fibrillation. Transesophageal echocardiography is, however, an invasive method for patients with ischemic stroke during rt-PA therapy. High resolution enhanced CT could be a useful tool and may be a reliable alternative to transthoracic echocardiography. Careful assessment of thromboembolic complications following rt-PA therapy in patients with arterial fibrillation is needed. In this case report and mini review, we would like to discuss about the accurate diagnostic methods to detect cardiac or undetermined embolic sources and provide expedited stroke care. These embolic sources may be more readily discovered during rt-PA therapy within the limited therapeutic time window.
Publisher
Walter de Gruyter GmbH
Reference30 articles.
1. Hacke W., Donnan G., Fieschi C., Kaste M., von Kummer R., Broderick JP.,et al., Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials, Lancet (London, England)., 2004, 363(9411), 768-774 2. Lees KR., Bluhmki E., von Kummer R., Brott TG.,Toni D., Grotta JC., et al., Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials, Lancet (London, England) ., 2010, 375(9727), 1695-1703 3. Yamaguchi T., Mori E., Minematsu K., Nakagawara J.,Hashi K.,Saito I., et al., Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT), Stroke., 2006, 37(7), 1810-1815 4. Furie KL.,Kasner SE., Adams RJ., Albers GW.,Bush RL., Fagan SC., et al., Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association, Stroke., 2011, 42(1), 227-276 5. Stafford PJ.,Strachan CJ., Vincent R., Chamberlain DA., Multiple microemboli after disintegration of clot during thrombolysis for acute myocardial infarction, BMJ (Clinical research ed)., 1989, 299(6711), 1310-1312
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|